Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21058154 | 0.85 | HTT (0.34) | HTTMAPT | |
| SCHEMBL21986538 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL21986526 | 0.82 | POLB (0.31) | ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL21986533 | 0.81 | HTT (0.34) | HTTALDH1A1 | |
| SCHEMBL14991449 | 0.80 | EGFR (0.37) | ALDH1A1MEN1LMNACYP3A4CYP2C9 | |
| SCHEMBL575219 | 0.76 | HTT (0.37) | HTT | |
| SCHEMBL28125185 | 0.74 | — | — | |
| SCHEMBL25849717 | 0.74 | TSHR (0.36) | — | |
| SCHEMBL14462578 | 0.72 | HTT (0.48) | HTTALDH1A1MEN1LMNACYP3A4 | |
| SCHEMBL21758880 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114097123-B | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2024-09-06 | — | — | CN | disclosed |
| CN-111788722-B | Electrode for secondary battery and method for manufacturing same | SK新能源株式会社 | 2024-07-09 | — | — | CN | disclosed |
| CN-118104028-A | Nonaqueous electrolyte, nonaqueous electrolyte battery and compound | 中央硝子株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-118056307-A | Nonaqueous electrolyte, nonaqueous electrolyte battery, compound, and additive for nonaqueous electrolyte | 中央硝子株式会社 | 2024-05-17 | — | — | CN | disclosed |
| CN-117981134-A | Nonaqueous solution, holding method, and nonaqueous battery | 中央硝子株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-117954689-A | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-111816943-B | Pretreatment method of lithium secondary battery | SK新能源株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-111448704-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2024-01-12 | — | — | CN | disclosed |
| CN-117121254-A | Nonaqueous electrolyte, nonaqueous electrolyte battery, and method for producing nonaqueous electrolyte battery | 中央硝子株式会社 | 2023-11-24 | — | — | CN | disclosed |
| CN-116918123-A | Nonaqueous electrolyte, nonaqueous electrolyte battery, and compound | 中央硝子株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-116711119-A | Nonaqueous electrolyte, nonaqueous electrolyte battery, and compound | 中央硝子株式会社 | 2023-09-05 | — | — | CN | disclosed |
| CN-116711120-A | Nonaqueous electrolyte, nonaqueous electrolyte battery, and compound | 中央硝子株式会社 | 2023-09-05 | — | — | CN | disclosed |
| CN-111527636-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-08-15 | — | — | CN | disclosed |
| CN-111433962-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-07-14 | — | — | CN | disclosed |
| EP-4011875-A1 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2022-06-15 | — | — | EP | disclosed |
| EP-3710438-B1 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-20 | — | — | EP | disclosed |
| US-10662172-B2 | Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-05-26 | — | — | US | disclosed |
| US-20190185446-A1 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185446-A1 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | LPAR3, LPAR1, LPAR2 | HTT 3151/4885ALDH1A1 3478/4885MEN1 3048/4885 |
| US-10662172-B2 | Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists | LPAR3, LPAR1, LPAR2 | HTT 3151/4885ALDH1A1 3478/4885MEN1 3048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.